United Kingdom · Question · Written question
UIN 79490
Coronavirus: Screening
Original
Introduced
22 November 2021
Last action
10 January 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
10 January 2022
Summary
To ask the Secretary of State for Health and Social Care, with reference to the US Food and Drug Administration communication on 10 June 2021, whether he has requested or received any advice on the efficacy of Innova Medical Group's SARS-CoV-2 Antigen Rap
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 November 2021
Written question
To ask the Secretary of State for Health and Social Care, with reference to the US Food and Drug Administration communication on 10 June 2021, whether he has requested or received any advice on the efficacy of Innova Medical Group's SARS-CoV-2 Antigen Rap
Source: Commons
10 January 2022
Answer
Following the safety notice issued on 10 June, the Medicines and Healthcare product Regulatory Agency (MHRA) requested briefing from the United States Food and Drug Administration, which confirmed it had no additional information.NHS Test and Trace invest...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-11-22/79490
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1380904
- uk · wq-1380904 · source updated 10 January 2022